Cargando…

Comparison of disease-severity measures within severe and very severe COPD patients: results from a nationally representative chart review and patient survey

OBJECTIVE: This study aimed to compare spirometry- and risk + symptom-based classification systems to physician-based severity assessment and find which system is most predictive of patient-reported health status, as measured by the St George’s Respiratory Questionnaire for COPD (chronic obstructive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solem, Caitlyn T, Sun, Shawn X, Liu, Sizhu, Macahilig, Cynthia, Katyal, Monica, Gao, Xin, Shorr, Andrew F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181550/ https://www.ncbi.nlm.nih.gov/pubmed/25284999 http://dx.doi.org/10.2147/COPD.S66798

Ejemplares similares

Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease
por: Solem, Caitlyn T, et al.
Publicado: (2013)

The Level of Cholesterol in COPD Patients with Severe and Very Severe Stage of the Disease
por: Zafirova-Ivanovska, Beti, et al.
Publicado: (2016)

Risk factors for cardiovascular disease in patients with COPD: mild-to-moderate COPD versus severe-to-very severe COPD
por: Caram, Laura Miranda de Oliveira, et al.
Publicado: (2016)

The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease
por: Stojkovikj, Jagoda, et al.
Publicado: (2016)

Influence of real-world characteristics on outcomes for patients with methicillin-resistant Staphylococcal skin and soft tissue infections: a multi-country medical chart review in Europe
por: Nathwani, Dilip, et al.
Publicado: (2014)

Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland
por: Samyshkin, Yevgeniy, et al.
Publicado: (2013)

Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
por: Calverley, Peter M, et al.
Publicado: (2016)

Impact of chemotherapy in the prognosis of non-small-cell lung cancer patients with severe to very severe COPD
por: Dong, Weigang, et al.
Publicado: (2018)

Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and brochodilators for severe and very severe COPD patients
por: Negro, Roberto Dal, et al.
Publicado: (2007)

Costs and Cost Drivers Associated with Non-Small-Cell Lung Cancer Patients Who Received Two or More Lines of Therapy in Europe
por: Verleger, Katharina, et al.
Publicado: (2020)

Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims
por: Mapel, Douglas W, et al.
Publicado: (2011)

Effects of exercise-based pulmonary rehabilitation on severe/very severe COPD: a systematic review and meta-analysis
por: He, Wenqing, et al.
Publicado: (2023)

Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis
por: Solem, Caitlyn T., et al.
Publicado: (2016)

Intra- and inter-rater reproducibility of the 6-minute walk test and the 30-second sit-to-stand test in patients with severe and very severe COPD
por: Hansen, Henrik, et al.
Publicado: (2018)

Inter-Day Test–Retest Reproducibility of the CAT, CCQ, HADS and EQ-5D-3L in Patients with Severe and Very Severe COPD
por: Hansen, Henrik, et al.
Publicado: (2021)

Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD
por: Tashkin, Donald P, et al.
Publicado: (2014)

Long-term safety of tiotropium/olodaterol in older patients with moderate-to-very-severe COPD in the TONADO® studies
por: Ferguson, Gary T., et al.
Publicado: (2020)

Plasma homocysteine is elevated in COPD patients and is related to COPD severity
por: Seemungal, Terence AR, et al.
Publicado: (2007)

Early-switch/early-discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections: proof of concept in the United Arab Emirates
por: El Houfi, Ashraf, et al.
Publicado: (2015)

Caring for the Patient with Severe or Very Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Montoya, Jose G., et al.
Publicado: (2021)

Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa
por: Millares, L., et al.
Publicado: (2014)

Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model
por: Wilson, Michele R, et al.
Publicado: (2017)

Evaluation of the Characteristics of Asthma in Severe and Extremely Severe COPD
por: Chen, Feng-jia, et al.
Publicado: (2019)

Can early introduction of specialized palliative care limit intensive care, emergency and hospital admissions in patients with severe and very severe COPD? a randomized study
por: Weber, Catherine, et al.
Publicado: (2014)

Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy vs triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK
por: Kiff, Chris, et al.
Publicado: (2018)

Central arterial stiffness is increased among subjects with severe and very severe COPD: report from a population-based cohort study
por: Qvist, Linnea, et al.
Publicado: (2015)

Sarcopenia in COPD: relationship with COPD severity and prognosis
por: Costa, Tatiana Munhoz da Rocha Lemos, et al.
Publicado: (2015)

A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD
por: Andreas, Stefan, et al.
Publicado: (2020)

Long-term safety of tiotropium/olodaterol Respimat(®) in patients with moderate-to-very severe COPD and renal impairment in the TONADO(®) studies
por: LaForce, Craig, et al.
Publicado: (2018)

Predictors of mortality in children due to severe and very severe pneumonia
por: Bokade, Chandrakant M., et al.
Publicado: (2015)

Blood Smear in a Patient With Very Severe Hypertriglyceridemia
por: Chernwipasakul, Onrampha, et al.
Publicado: (2017)

Patients with very severe anemia: a case series
por: Cei, Marco, et al.
Publicado: (2017)

Impact of cardiovascular comorbidities on COPD Assessment Test (CAT) and its responsiveness to pulmonary rehabilitation in patients with moderate to very severe COPD: protocol of the Chance study
por: Smid, Dionne E, et al.
Publicado: (2015)

Cognitive and Functional Deterioration in Patients with Severe COPD(1)
por: Özge, Cengiz, et al.
Publicado: (2006)

The clinical characteristics of myocardial injury in severe and very severe patients with 2019 novel coronavirus disease
por: Zhou, Bo, et al.
Publicado: (2020)

Development and Implementation of a National Programme for the Management of Severe and Very Severe Pneumonia in Children in Malawi
por: Enarson, Penelope Marjorie, et al.
Publicado: (2009)

Exacerbations among chronic bronchitis patients treated with maintenance medications from a US managed care population: an administrative claims data analysis
por: AbuDagga, Azza, et al.
Publicado: (2013)

Effect of joint mobilization and stretching on respiratory function and spinal movement in very severe COPD with thoracic kyphosis
por: Wang, Joong-San
Publicado: (2015)

Association of MMP - 12 polymorphisms with severe and very severe COPD: A case control study of MMPs - 1, 9 and 12 in a European population
por: Haq, Imran, et al.
Publicado: (2010)

Effects of a comprehensive, inpatient pulmonary rehabilitation programme in a cachectic patient with very severe COPD and chronic respiratory failure
por: Franssen, Frits M.E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dsp8s3g2m6u7npo45cvmb0ag9t